We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,090.00
Bid: 1,090.00
Ask: 1,094.00
Change: 6.00 (0.55%)
Spread: 4.00 (0.367%)
Open: 1,110.00
High: 1,110.00
Low: 1,078.00
Prev. Close: 1,084.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Apr 2018 10:00

RNS Number : 0946L
Savills PLC
17 April 2018
 

SAVILLS PLC (THE "COMPANY")

NOTIFICATION OF INTERESTS OF DIRECTORS/ PDMRs

 

Grant of Share Awards

 

The Company announces that on 16 April 2018 the grant of the share based element of 2017 profit share awards has been made under the Savills Deferred Share Bonus Plan and the Savills Deferred Share Plan (the "Deferred Share Plans") to Directors and other persons discharging managerial responsibilities ("PDMRs") as follows:-

 

Director/ PDMR

Number of shares subject to the Deferred Share Plans awarded to the Director / PDMR on 16 April 2018

Resulting beneficial interest under the Deferred Share Plans

Jeremy Helsby (Director)

70,250

294,274

Simon Hope (PDMR)

7,680

50,493

Chris Lee (PDMR)

11,879

65,664

Christian Mancini (PDMR)

8,875

67,222

Robert McKellar (PDMR)

15,360

116,386

Justin O'Connor (PDMR)

24,577

141,517

Mark Ridley (PDMR)

46,492

211,475

Simon Shaw (Director)

52,534

213,744

 

The Company announces that on 16 April 2018 the grant of the share based element of 2017 profit share awards has been made under The Schedule to The Savills Deferred Share Bonus Plan to PDMRs based in the United States of America as follows:-

 

PDMR

Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the PDMR on 16 April 2018

Resulting beneficial interest under the Savills Deferred Share Bonus Plan

Michael Colacino (PDMR)

9,399

40,464

Mitchell Steir (PDMR)

7,355

31,630

All the above awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

\* The resulting beneficial interest for Justin O'Connor (CEO, Savills Investment Management) includes an award over 55,575 shares made on 20 June 2016 under the Savills Deferred Share Plan whereby 30% of the award vests subject to continued employment in March 2019, with 70% vesting subject to the satisfaction of performance criteria relating to the financial performance of Savills Investment Management, including the performance of funds managed by Savills Investment Management, over the period to 31 December 2018.

 

The Company announces that on 16 April 2018 awards have been made under The Savills plc Performance Share Plan (the "Performance Share Plan") to Directors and PDMRs as follows:- 

 

Director/ PDMR

Number of shares subject to the Performance Share Plan awarded to the Director / PDMR on 16 April 2018

Total number of shares subject to Performance Share Plan Awards following this notification

Jeremy Helsby (Director)

59,190

265,740

Chris Lee (PDMR)

23,041

69,983

Mark Ridley (PDMR)

43,010

156,181

Simon Shaw (Director)

45,263

170,629

The Performance Share Plan provides for the award of nil cost options or conditional awards of ordinary shares in the Company.

Awards of shares are made subject to a three-year performance period. Awards which satisfy the applicable performance criteria (as below) in the three-year performance period will then vest after an additional two-year holding period.

Awards vest subject to the satisfaction of the following performance criteria measured over the three years following grant:

(a) 50% of the initial value of an award is subject to the Company's Total Shareholder Return ('TSR') performance measured against the TSR of the FTSE Mid 250 Index (excluding investment trusts);

(b) the other 50% of the initial value of an award is subject to real (i.e. growth in excess of RPI) Group Earnings per Share ('EPS') growth performance.

Awards vest as follows:

(a) for the TSR linked part of an award, 25% (i.e. threshold) will vest if the Company's TSR matches Index performance, rising to 100% (i.e. maximum) if the Company's TSR outperforms the Index by 8% p.a., compound with sliding scale vesting between the two points; and

(b) for the EPS growth linked part of an award, 25% (i.e. threshold) will vest if the Company's real EPS growth (i.e. growth in excess of RPI) is 3% p.a., compound rising to 100% (i.e. maximum) if the Company's real (i.e. growth in excess of RPI) EPS growth is 8% p.a., compound with sliding scale vesting between the two points.

 

 

17 April 2018

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFMGMDNVLGRZM
Date   Source Headline
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding
1st Feb 202411:00 amRNSTotal Voting Rights
22nd Jan 20249:11 amRNSBlock listing Interim Review
11th Jan 20244:02 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNSYear End Trading Update
2nd Jan 202412:33 pmRNSTotal Voting Rights
15th Dec 202310:00 amRNSAdditional Listing
14th Dec 202312:56 pmRNSDirector/PDMR Shareholding
13th Dec 202311:42 amRNSNon-Executive Director Appointment
13th Nov 20232:02 pmRNSSAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA
13th Nov 202312:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20233:16 pmRNSForm 8.3 - OntheMarket PLC
1st Nov 202310:00 amRNSTotal Voting Rights
27th Oct 202310:00 amRNSAdditional Listing
12th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20238:50 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSAdditional Listing
12th Sep 20235:10 pmRNSTotal Voting Rights
1st Sep 202311:00 amRNSTotal Voting Rights
18th Aug 20232:00 pmRNSAdditional Listing
15th Aug 20234:06 pmRNSBlock listing Interim Review
14th Aug 20232:05 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSChair Succession
10th Aug 20237:00 amRNSHalf-year Report
21st Jul 202310:00 amRNSBlock listing Interim Review
11th Jul 202312:50 pmRNSDirector/PDMR Shareholding
4th Jul 20239:20 amRNSTotal Voting Rights
13th Jun 20235:31 pmRNSDirector/PDMR Shareholding
1st Jun 202310:00 amRNSTotal Voting Rights
17th May 20234:05 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Statement
11th May 20236:12 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20235:15 pmRNSDirector/PDMR Shareholding
12th Apr 20232:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:15 pmRNSAnnual Report and AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.